News (569)

Deutsche Bank : Declaration of conformity according to §17 Abs. 1 Nr. 18b PFAV PU
Transcript : Biohaven Ltd. - Special Call
Deutsche Bank : General Meeting 2024 Voting results - Form 6-K PU
Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders PR
Transcript : Oncolytics Biotech Inc. - Shareholder/Analyst Call
Ams-OSRAM AG: ams OSRAM has published the proposals for the Annual General Meeting 2024 and expects Dr. Margarete Haase to continue as Chairwoman of the Supervisory Board EQ
DynaCERT Appoints Bernd Krueper as President & Director, Expanding Leadership Team for Global Growth and Innovation BU
DynaCERT Inc. Announces Management Changes CI
Ams-OSRAM AG: ams OSRAM sells Passive Optical Components assets to Focuslight Technologies Inc. for EUR 45 million in cash EQ
DD: Your Family Entertainment AG: Bernd Wendeln, Exercise of a purchase option for 200,000 shares on the basis of an option agreement. EQ
Sernova Announces AGM Voting Results AQ
Ams OSRAM : delivers like-for-like structural growth with solid Q1, restructures microLED development and works on exiting 8-inch-wafer factory SLB, accelerating path to positive free cash flow PU
Ams-OSRAM AG: delivers solid Q1 revenues of EUR 847m, adj. EBIT margin of 5.2%, restructures microLED development, works on exiting 8-inch fab SLB, on track for positive FCF (after interest) in 2025 EQ
Ams-OSRAM AG: ams OSRAM has published the Annual Report 2023 EQ
RWE : Countermotions PU
Mercedes Benz : Convocation (searchable) PU
Oncolytics Biotech : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 15, 2024 MANAGEMENT INFORMATION CIRCULAR - Form 6-K PU
Dpa-AFX Overview: COMPANIES from 10.04.2024 - 15:15 DP
DEUTZ : Notice of the Annual General Meeting PU
Deutsche Bank : Agenda short version PU
Knorr Bremse : Compensation report 2023 PU
Knorr Bremse : Declaration on Corporate Governance 2023 PU
DEUTZ : Corporate Governance Declaration and Corporate Governance Report 2023 PU
DEUTZ : Remuneration Report 2023 PU
Your Family Entertainment AG and Salzburg AG extend cooperation agreement for Fix&Foxi TV until the end of 2028 EQ
GEA : Transcript zum Analysten-Call (nur englisch) PU
GEA : Analyst Conference Call FY 2023 - transcript PU
Gulf Hotels B S C : Click here to view the Annual Report 2023 (English) PU
Heidelberg Materials : Governance Presentation 2024 PU
Transcript : Cicor Technologies Ltd., 2023 Earnings Call, Mar 06, 2024
SpringWorks Therapeutics Announces European Medicines Agency Validation for Marketing Authorization Application of Nirogacestat for the Treatment of Adults with Desmoid Tumors GL
SpringWorks Therapeutics Announces European Medicines Agency Validation for Marketing Authorization Application of Nirogacestat for the Treatment of Adults with Desmoid Tumors AQ
Ams-OSRAM AG: to re-assess its microLED strategy, to record non-cash impairment charges, to adjust its mid-term structural revenue growth target to 6% to 8%, and to improve cash flow profile EQ
Ams OSRAM delivers solid Q4, with revenues and adj. EBIT above the mid-point of the guided range, and continues executing its turnaround plan to benefit from structural growth EQ
Your Family Entertainment AG takes the next step and presses ahead with its international expansion EQ
Q.beyond gains Thorsten Dirks as new Supervisory Board member EQ
Ams OSRAM successfully completes its comprehensive financing plan reaching a healthy capital structure EQ
Ams OSRAM successfully sells remaining shares following its rights issue, securing 808 million Euro gross proceeds from rights issue EQ
Ams OSRAM announces preliminary results of exercise period in fully underwritten rights issue with 99.0% take-up of rights EQ
Software AG -Cumulocity IoT platform is now available as-a-service for international customers in China through Tencent Cloud AQ
Ams-OSRAM AG: ams OSRAM announces terms of fully underwritten Rights Issue EQ
Ams-OSRAM AG: ams OSRAM announces the successful pricing of an upsized offering of senior notes, bringing forward the final component of its previously announced holistic financing plan EQ
GEA GROUP : Higher profitability despite the FX tailwinds Alphavalue
Ams OSRAM announces the offering of EUR 800 million equivalent senior notes as part of its recently presented financing plan EQ
SpringWorks Therapeutics Announces Presentation of Additional Data from Phase 3 DeFi Trial of Nirogacestat in Adults with Desmoid Tumors at the 2023 CTOS Annual Meeting GL
1234NextSee all

Companies (533)

T-MOBILE US 208 B $
Logo T-Mobile US

T-Mobile US, Inc. specializes in mobile telecommunication services. Sales break down by activity as follows: - mobile telecommunication services (80.5%): mobile telephone service, long-distance telephone service, data transmission, Internet access, direc ...

AT&T INC. 127 B $
Logo AT&T Inc.

AT&T Inc. is one of the leading American telecommunication operators. The activity is organized mainly around two areas: - mobile telephony; - fixed telephony and cable services: local and long-distance telephony services. The group also offers broadban ...

FERRARI N.V. 74 820 M $
Logo Ferrari N.V.

Ferrari N.V. is a holding company organized around 3 areas of activity: - manufacturing and sale of luxury sports vehicles (85.8% of net sales): 458 Italia, 488 GTB, 458 Spider, 488 Spider, F12 Berlinetta, 458 Speciale, 458 Speciale A, California T and F ...

T. ROWE PRICE GROUP INC. 26 135 M $
Logo T. Rowe Price Group Inc.

T. Rowe Price Group, Inc. is an investment management company that provides investment advisory services to individual and institutional investors, retirement plans, and financial intermediaries. The group manages a broad range of American and internation ...

ALNYLAM PHARMACEUTICALS, INC. 19 897 M $
Logo Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc. is a clinical-stage company. The Company is engaged in developing mRNA cell therapies for the treatment of autoimmune diseases. The Company’s lead product candidate, Descartes-08, is an autologous mRNA CAR-T directed agains ...

TELSTRA GROUP LIMITED 27 038 M $
Logo Telstra Group Limited

Telstra Group Limited is an Australia-based telecommunications and technology company, offering a full range of communications services. The Company’s segments include Telstra Consumer and Small Business (TC&SB), Telstra Enterprise (TE), Networks, IT an ...

CHOW TAI FOOK JEWELLERY GROUP LIMITED 11 176 M $
Logo Chow Tai Fook Jewellery Group Limited

Chow Tai Fook Jewellery Group Limited specializes in the design, manufacture and marketing of luxury jewelry in platinum, gold and precious stones (sapphire, diamond, ruby, etc.). The group offers necklaces, earrings, rings, bracelets, pendants, etc. (Cho ...

M&T BANK CORPORATION 24 159 M $
Logo M&T Bank Corporation

M&T Bank Corporation is a banking group organized around 7 business sectors: - retail banking (29.4% of net interest income): sales of standard and specialized banking products and services (leasing, factoring, insurance, etc.); - commercial banking (22 ...

LULULEMON ATHLETICA INC. 39 114 M $
Logo lululemon athletica Inc.

lululemon athletica Inc. specializes in the design and marketing of technical sportswear for men and women. The group offers pants, t-shirts, shorts, jerseys, jackets, etc. as well as accessories (socks, shoes, rugs, bags, water bottles, etc.). Net sales ...

SAMSUNG C&T CORPORATION 15 277 M $
Logo Samsung C&T Corporation

Samsung C&T Corp is a Korea-based company principally engaged in the trading of industrial goods. The Company operates its business through six segments. The Trading segment is mainly engaged in the trading of chemicals, steel, natural materials, and livi ...

BIONTECH SE 21 342 M $
Logo BioNTech SE

BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell ...

KEURIG DR PEPPER INC. 47 025 M $
Logo Keurig Dr Pepper Inc.

Keurig Dr Pepper Inc. is is a leading producer of non-alcoholic beverages in North America. The group markets hot drinks, soft drinks, flavoured water, fruit juices, concentrated and syrups. Net sales break down by family of products as follows: - refres ...

T&D HOLDINGS INC. 8 695 M $
Logo T&D Holdings Inc.

T&D Holdings, Inc. is a holding company detaining shares in the life insurance companies Taiyo Life, Daido Life and T&D Financial Life. ...

LEGEND BIOTECH CORPORATION 7 565 M $
Logo Legend Biotech Corporation

Legend Biotech Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), refe ...

GLAXOSMITHKLINE PHARMACEUTICALS LIMITED 5 403 M $
Logo GlaxoSmithKline Pharmaceuticals Limited

GlaxoSmithKline Pharmaceuticals Limited is an India-based global healthcare company. The Company is engaged in the business of manufacturing, distributing and trading in pharmaceuticals. It has three product areas: vaccines, specialty and general medicine ...

REGIONAL EXPRESS HOLDINGS LIMITED 49 M $
Logo Regional Express Holdings Limited

Regional Express Holdings Limited is an Australia-based company engaged in the provision of air services, including the transportation of passengers and freight, along with aeromedical services and pilot training. The Company's segments include regular pu ...

HLA GROUP CORP., LTD. 6 109 M $
Logo Hla Group Corp., Ltd.

HLA GROUP CORP LTD, formerly Hla Corp Ltd, is a China-based company, principally engaged in the operation of branded garments, and the production and sales of high-end suits and business wear. The operations of branded garments include the management of b ...

BAIC BLUEPARK NEW ENERGY TECHNOLOGY CO.,LTD. 5 707 M $
Logo BAIC BluePark New Energy Technology Co.,Ltd.

BAIC BluePark New Energy Technology Co Ltd is a China-based company mainly engaged in the research, development, design, manufacturing, sales and service of pure electric passenger vehicles. The Company mainly owns the two brands of Jihu and BEIJING. Its ...

J&T GLOBAL EXPRESS LIMITED 9 398 M $
Logo J&T Global Express Limited

J&T Global Express Ltd is a China-based company principally engaged in global logistics services. The Company's businesses include express delivery services, cross-border logistics services, sales accessories and other services. The express delivery servi ...

VALMONT INDUSTRIES, INC. 5 492 M $
Logo Valmont Industries, Inc.

Valmont Industries, Inc. is a manufacturer of products and services for infrastructure and agricultural markets. The Company operates through two segments: Infrastructure and Agriculture. The Infrastructure segment consists of the manufacture and distribu ...

L&T TECHNOLOGY SERVICES LIMITED 6 139 M $
Logo L&T Technology Services Limited

L&T Technology Services Limited is an India-based engineering research and development (ER&D) services provider. The Company offers consultancy, design, development and testing services across the product and process development life cycle. The Company op ...

LI NING COMPANY LIMITED 5 973 M $
Logo Li Ning Company Limited

Li Ning Company Limited is specialized in designing, manufacturing and marketing clothing, shoes and sports equipment. The group offers products under its own brand (LI-NING) and licensed brands (Double Happiness, AIGLE, Danskin, Kason and Lotto). Net sal ...

FIVE BELOW, INC. 6 295 M $
Logo Five Below, Inc.

Five Below, Inc. is a specialty value retailer offering merchandise targeted at the tween and teen demographic. Its assortment of products, including select brands and licensed merchandise. It is engaged in offering a group of products, including leisure, ...

MEDIGENE AG 40 M $
Logo Medigene AG

Medigene AG is a Germany-based biotechnology company that develops treatment platforms to target various types and stages of cancer with candidates in clinical and pre-clinical development. The Company focuses on the development of personalized T cell-bas ...

GILDAN ACTIVEWEAR INC. 6 373 M $
Logo Gildan Activewear Inc.

Gildan Activewear Inc. is a vertically integrated manufacturer of everyday basic apparel, including activewear, underwear, and hosiery products. Its primary product categories include activewear tops and bottoms (activewear), socks (hosiery), and underwea ...

THAI SUGAR TERMINAL 155 M $
Logo Thai Sugar Terminal

TSTE Public Company Limited, formerly Thai Sugar Terminal Public Company Limited, is a Thailand-based company, which is a provider of logistics services. It operates businesses relating to transfer and transportation services for sugar and certain agricul ...

AUTOLUS THERAPEUTICS PLC 1 147 M $
Logo Autolus Therapeutics plc

Autolus Therapeutics plc is a United Kingdom-based clinical-stage biopharmaceutical company developing programmed T cell therapies for the treatment of cancer and autoimmune diseases. It is focused on chimeric antigen receptor (CAR)-T cell therapy. Using ...

CUROCELL INC. 308 M $
Logo Curocell Inc.

Curocell Inc is a Korea-based company principally engaged in the manufacture, research and development (R&D) of drugs. The Company is also engaged in the development of novel chimeric antigen receptor (CAR)-T therapy technologies targeting novel cancer an ...

TC BIOPHARM (HOLDINGS) PLC 5 M $
Logo TC Biopharm (Holdings) Plc

TC BioPharm Limited is a clinical-stage cell therapy company. The Company is engaged in developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infecti ...

CERO THERAPEUTICS HOLDINGS, INC. 5 M $
Logo CERo Therapeutics Holdings, Inc.

CERo Therapeutics Holdings, Inc. is an immunotherapy company advancing the development of engineered T cell therapeutics for the treatment of cancer. The Company’s proprietary approach to T cell engineering, enables it to integrate certain desirable cha ...

ATARA BIOTHERAPEUTICS, INC. 51 M $
Logo Atara Biotherapeutics, Inc.

Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company. The Company is a developer of T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with s ...

LUX INDUSTRIES LIMITED 527 M $
Logo Lux Industries Limited

Lux Industries Limited is an India-based company, which is primarily engaged in the business of manufacturing knitted garments. The Company's products include men's, women's and kids' innerwear, winterwear, socks and slacks for women in varied colors and ...

CYTOMED THERAPEUTICS LIMITED 23 M $
Logo CytoMed Therapeutics Limited

CytoMed Therapeutics Limited is a pre-clinical biopharmaceutical company. The Company is focused on harnessing its licensed proprietary technologies to create cell-based immunotherapies for the treatment of human cancers. The development of its technologi ...

TSCAN THERAPEUTICS, INC. 393 M $
Logo TScan Therapeutics, Inc.

TScan Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of T cell receptor-engineered T cell (TCR-T), therapies for the treatment of patients with cancer. The Company’s lead TCR-T therapy c ...

ADAPTIMMUNE THERAPEUTICS PLC 239 M $
Logo Adaptimmune Therapeutics plc

Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. The Company is focused on providing cell therapies to people with cancer. Its engineered T-cell receptor (TCR) platform enables the engineering of T-cells to target and destroy ca ...

MUSTANG BIO, INC. 21 M $
Logo Mustang Bio, Inc.

Mustang Bio, Inc. is a clinical-stage biopharmaceutical company focused on translating medical breakthroughs in cell and gene therapies into potential cures for cancers and rare genetic diseases. The Company has partnered with medical institutions to adva ...

KALTURA, INC. 191 M $
Logo Kaltura, Inc.

Kaltura, Inc. is a video technology provider. The Company's segments include Enterprise, Education, and Technology (EE&T) and Media and Telecom (M&T). The EE&T segment represents products related to industry solutions for education customers, and media se ...

MAGYAR TELEKOM TÁVKÖZLÉSI NYILVÁNOSAN MÜKÖDÖ RÉSZVÉNYTÁRSASÁG 2 585 M $
Logo Magyar Telekom Távközlési Nyilvánosan Müködö Részvénytársaság

Magyar Telekom Tavkozlesi Nyrt is engaged in providing fixed line and mobile telecommunication services for public and business customers. The Company's segments include Telekom Hungary, T-Systems, Macedonia and Montenegro. Its Telekom Hungary segment ope ...

GRACELL BIOTECHNOLOGIES INC. 991 M $
Logo Gracell Biotechnologies Inc.

Gracell Biotechnologies Inc is a China-based clinical-stage biopharmaceutical company focused on discovering and developing cell therapies for the treatment of cancers. The Company is primarily focused on disrupting conventional approaches to chimeric ant ...

T&R BIOFAB CO., LTD. 98 M $
Logo T&R Biofab Co., Ltd.

T&R Biofab Co., Ltd. is a Korea-based company mainly engaged in the production and sale of bioresorbable scaffolds. The bioresorbable scaffolds are sold under the name of T&R mesh and T&R Dental Mesh. In addition, the Company is involved in the production ...

SNT HOLDINGS CO., LTD. 225 M $
Logo SNT Holdings Co., Ltd.

SNT Holdings Co Ltd, formerly S&T Holdings Co Ltd, is a Korea-based holding company engaged in the management of its subsidiaries. Through its subsidiaries, the Company operates in four business divisions: automobile parts division, which manufactures axl ...

RECTIFIER TECHNOLOGIES LIMITED 7 M $
Logo Rectifier Technologies Limited

Rectifier Technologies Limited is an Australia-based company, which designs and manufactures high-efficiency power rectifiers and produces electronic and specialized magnetic components. The Company's segments include Electronic Components, Industrial Pow ...

NCR ATLEOS CORPORATION 2 080 M $
Logo NCR Atleos Corporation

NCR Atleos Corporation is a financial technology company providing self-directed banking solutions to a global customer base, including financial institutions, merchants, manufacturers, retailers and consumers. The Company's solutions enable the accelerat ...

IN8BIO, INC. 44 M $
Logo IN8bio, Inc.

IN8bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of gamma-delta T cell-based immunotherapies for cancer patients. Gamma-delta T cells are a specialized population of T c ...

ADICET BIO, INC. 108 M $
Logo Adicet Bio, Inc.

Adicet Bio, Inc. is a clinical stage biotechnology company. The Company is engaged in advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. Its lead produc ...

ANIXA BIOSCIENCES, INC. 83 M $
Logo Anixa Biosciences, Inc.

Anixa Biosciences, Inc. is a biotechnology company developing vaccines and therapies that are focused on critical unmet needs in oncology. Its segments include CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics and Other. Its vaccine programs in ...

SNT ENERGY CO., LTD. 142 M $
Logo SNT Energy Co., Ltd.

SNTEnergy Co Ltd, formerly S&T Corp, is a Korea-based company engaged in the manufacture and sale of heat exchangers. The Company manufactures heat exchangers, which are used for petrochemical plants, oil refining plants, gas plants and others; heat recov ...

GUOBO ELECTRONICS CO., LTD. 4 046 M $
Logo Guobo Electronics Co., Ltd.

Guobo Electronics Co Ltd is a China-based company mainly engaged in the research and development, production and sales of active phased array transmitter and receiver (T/R) components and radio frequency integrated circuits related products. The Company's ...

ALLOGENE THERAPEUTICS, INC. 480 M $
Logo Allogene Therapeutics, Inc.

Allogene Therapeutics, Inc. is a clinical-stage immuno-oncology company. The Company is focused on development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. It is focused on four core p ...

MARKER THERAPEUTICS, INC. 43 M $
Logo Marker Therapeutics, Inc.

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company. The Company specializes in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. It h ...

CONNECT BIOPHARMA HOLDINGS LIMITED 91 M $
Logo Connect Biopharma Holdings Limited

Connect Biopharma Holdings Limited is a global clinical-stage biopharmaceutical company focused on improving the lives of patients with chronic inflammatory diseases through the development of therapies derived from T cell-driven research. It is building ...

IMUGENE LIMITED 280 M $
Logo Imugene Limited

Imugene Limited is a clinical-stage immune-oncology company. It is engaged in developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Its platform technology seeks to ha ...

CARGO THERAPEUTICS, INC. 627 M $
Logo CARGO Therapeutics, Inc.

CARGO Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in advancing curative cell therapies for cancer patients. Its programs, platform technologies, and manufacturing strategy are designed to directly address the chime ...

INTERNATIONAL KNITWEAR LIMITED 502 755 $
Logo International Knitwear Limited

International Knitwear Limited is a Pakistan-based company that is engaged in creating, developing and manufacturing knitted and woven apparel products. The Company is also engaged in the export of garments. Its product categories include men's wear, ladi ...

CELYAD ONCOLOGY SA 13 M $
Logo Celyad Oncology SA

Celyad Oncology SA is a biotechnology company focused on the discovery and development of innovative technologies chimeric antigen receptor (CAR) T-cell therapies. The company is focusing on opportunities to fully harness the true potential of its proprie ...

CABALETTA BIO, INC. 452 M $
Logo Cabaletta Bio, Inc.

Cabaletta Bio, Inc. is a clinical-stage biotechnology company. The Company is focused on the discovery and development of engineered T cell therapies that have the potential to provide deep and durable, perhaps curative, responses with one-time administra ...

KYVERNA THERAPEUTICS, INC. 340 M $
Logo Kyverna Therapeutics, Inc.

Kyverna Therapeutics, Inc. is a patient-centered, clinical-stage biopharmaceutical company. The Company is focused on developing cell therapies for patients suffering from autoimmune diseases. The Company's lead program, KYV-101, is an autologous CD19 CAR ...

MAFIA TRENDS LIMITED 822 111 $
Logo Mafia Trends Limited

Mafia Trends Limited is an India-based company that is engaged in the business of trading of apparels and readymade garments. The Company is involved in the business of marketing and selling of men's fashion, which includes apparels such as jeans, t-shirt ...

M&T 1997, 17 M $
Logo M&T 1997,

M&T 1997 as is a Czech Republic-based company primarily engaged in appliances, tools and housewares business industry. The Company is a producer and designer of various sizes and shapes, brass handles, door fittings and window fittings under the M & T bra ...

SANU GOLD CORP. 7 M $
Logo Sanu Gold Corp.

Sanu Gold Corp. is a Canada-based junior mineral exploration-stage company. The Company is exploring three gold exploration permits. Its projects include Bantabaye, Daina and Diguifara. The Bantabaye is located within the Siguiri Basin, approximately 70 k ...

GARMENT MANTRA LIFESTYLE LIMITED 8 M $
Logo Garment Mantra Lifestyle Limited

Garment Mantra Lifestyle Limited is an India-based company engaged in the business of manufacturing, selling and distribution of fabrics, hosiery garments and providing related services. The Company offer a range of fabric types and can apply coatings or ...

VIRAX BIOLABS GROUP LIMITED 4 M $
Logo Virax Biolabs Group Limited

Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The Company is engaged in developing a T-Cell Test technologies with the intention of providing an immunology profiling ...

THAI ENERGY STORAGE TECHNOLOGY 113 M $
Logo Thai Energy Storage Technology

Thai Energy Storage Technology PCL is a Thailand-based company, which is engaged in the manufacturing and distribution of batteries. The Company’s product categories include automotive battery, traction battery, EB battery, lighting battery, and golf ca ...

IMMUNOTECH BIOPHARM LTD 206 M $
Logo Immunotech Biopharm Ltd

Immunotech Biopharm Ltd is a China-based investment holding company mainly engaged in the research and development, manufacturing and commercialization of immune cell products for treatments of cancers. Its main products are EAL, CAR-T cell series and TCR ...

CORVUS PHARMACEUTICALS, INC. 121 M $
Logo Corvus Pharmaceuticals, Inc.

Corvus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of ITK inhibition as a new approach to immunotherapy for a range of cancer and immune diseases. Its lead product candidate is soquelitini ...

PDS BIOTECHNOLOGY CORPORATION 98 M $
Logo PDS Biotechnology Corporation

PDS Biotechnology Corporation is a clinical-stage immunotherapy company. The Company is developing a pipeline of targeted cancer immunotherapies based on its Versamune T cell-activator and Versamune in combination with its interleukin 12 (IL-12) fused ant ...

2SEVENTY BIO, INC. 210 M $
Logo 2seventy bio, Inc.

2seventy bio, Inc. is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The Company is focused on the commercialization and development of Abecma (idecabtagene vicleucel). ...

T&G GLOBAL LIMITED 127 M $
Logo T&G Global Limited

T&G Global Limited is a grower, distributor, marketer and exporter of fresh produce, which includes apples, berries, citrus (lemons, mandarins and navel oranges) and tomatoes. The Company's segments include Apples, International Trading, T&G Fresh, Ventur ...

KINETA, INC. 7 M $
Logo Kineta, Inc.

Kineta, Inc. is a clinical-stage biotechnology company. The Company has leveraged its expertise in innate immunity and is focused on discovering and developing potentially differentiated immunotherapies that address the mechanisms of cancer immune resista ...

PRESCIENT THERAPEUTICS LIMITED 22 M $
Logo Prescient Therapeutics Limited

Prescient Therapeutics Limited is an Australia-based clinical-stage oncology company. The Company is developing personalized medicine approaches to cancer, including targeted and cellular therapies. Its product pipeline includes PTX-100, PTX-200, OmniCAR, ...

CYTOMX THERAPEUTICS, INC. 107 M $
Logo CytomX Therapeutics, Inc.

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company focused on developing novel conditionally activated biologics designed to be localized to the tumor microenvironment. It is advancing potential first-in-class and be ...

SANA BIOTECHNOLOGY, INC. 1 329 M $
Logo Sana Biotechnology, Inc.

Sana Biotechnology, Inc. is a biotechnology company focusing on utilizing engineered cells as medicines. It is engaged in developing cell engineering programs to revolutionize treatment across an array of therapeutic areas with unmet treatment needs, incl ...

ALLOVIR, INC. 83 M $
Logo AlloVir, Inc.

AlloVir, Inc. is an allogeneic T cell immunotherapy company with a focus on restoring natural immunity against life-threatening viral diseases in pediatric and adult patients with weakened immune systems. The company’s proprietary technology platforms l ...

CARSGEN THERAPEUTICS HOLDINGS LIMITED 433 M $
Logo CARsgen Therapeutics Holdings Limited

CARsgen Therapeutics Holdings Ltd is a China-based investment holding company principally engaged in discovering, developing and commercializing innovative chimeric antigen receptor (CAR)-T cell therapies. The Company’s therapies are applied in the trea ...

ELICERA THERAPEUTICS AB 4 M $
Logo Elicera Therapeutics AB

Elicera Therapeutics AB is a Sweden-based clinical-stage immuno-oncology company. The Company is developing next-generation cell and gene therapies for immune-based treatment of cancer. The company is developing four drug candidates, two of which are in t ...

LYELL IMMUNOPHARMA, INC. 553 M $
Logo Lyell Immunopharma, Inc.

Lyell Immunopharma, Inc. is a clinical-stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for patients with solid tumors. The Company is engaged in enrolling a Phase I clinical trial evaluating a ROR1-targeted CAR T-cell the ...

CHIMERIC THERAPEUTICS LIMITED 10 M $
Logo Chimeric Therapeutics Limited

Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company. The Company is focused on the discovery, development, and commercialization of cell therapies for patients with cancer. Its pipeline includes CHM 1101 and CHM 2101. I ...

INSTIL BIO, INC. 65 M $
Logo Instil Bio, Inc.

Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first ...

VIGENCELL INC. 54 M $
Logo ViGenCell Inc.

ViGenCell Inc is a Korea-based company principally engaged in the development of cell therapy business. The Company is engaged in the development and manufacture of immuno-cancer cell therapy products and immunosuppressive cell therapy products. In additi ...

IMMUTEP LIMITED 395 M $
Logo Immutep Limited

Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing Lymphocyte Activation Gene (LAG)-3 immunotherapies for cancer and autoimmune diseases. Its lead product candidate, Eftilagimod alpha (efti or ...

CARTESIAN THERAPEUTICS, INC. 415 M $
Logo Cartesian Therapeutics, Inc.

Cartesian Therapeutics, Inc. is a clinical-stage company. The Company is engaged in developing messenger ribonucleic acids (mRNA) cell therapies for the treatment of autoimmune diseases. It is leveraging its proprietary technology and manufacturing platfo ...

NEXIMMUNE, INC. 4 M $
Logo NexImmune, Inc.

NexImmune, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing an approach to immunotherapy designed to employ the body’s own T cells to generate an immune response that mimics natural biology. Its product candidates inc ...

TRIMURTHI LIMITED 2 M $
Logo Trimurthi Limited

Trimurthi Limited is an India-based company, which is engaged in the business of trading of pharmaceuticals and related products and is into the business of trading of shares and securities. The Company's segments include Pharma Business, Financial Servic ...

CELL SOURCE, INC. 32 815 $
Logo Cell Source, Inc.

Cell Source, Inc. is a cell therapy company focused on immunotherapy. The Company is primarily focused on the development of immune system management technology (Veto Cell technology). Its lead prospective product is its Veto Cell immune system management ...

ALX ONCOLOGY HOLDINGS INC. 384 M $
Logo ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc. is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 immune checkpoint inhibitor and bridge the innate and adaptive immune system. Its product candidate ...

SHINE-ON BIOMEDICAL CO.,LTD. 101 M $
Logo Shine-On BioMedical Co.,Ltd.

Shine-On BioMedical Co Ltd is a Taiwan-based company mainly engaged in the research, development and manufacture of anti-cancer related new drug products. Antibody products include trispecific T cell engaging nanobody (SOA101), EphA10 trispecific antibody ...

FOXTRON VEHICLE TECHNOLOGIES CO., LTD. 2 417 M $
Logo Foxtron Vehicle Technologies Co., Ltd.

Foxtron Vehicle Technologies Co Ltd is a Taiwan-based company mainly engaged in the research and development of electric vehicle technology, the manufacture, management and sale of vehicle and component. The company's main products include an open platfor ...

TEVOGEN BIO HOLDINGS INC. 145 M $
Logo Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc. is a clinical-stage specialty immunotherapy company. The Company is harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs), to develop off-the-shelf, genetically unmodified precision T cell therapies for the treatment of infectious ...

JANUX THERAPEUTICS, INC. 2 078 M $
Logo Janux Therapeutics, Inc.

Janux Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. It has developed two bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr) ...

CUE BIOPHARMA, INC. 65 M $
Logo Cue Biopharma, Inc.

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells. The Company's platform, Immuno-STAT (Selective Targeting and Alteration of T cells) and b ...

CARIBOU BIOSCIENCES, INC. 158 M $
Logo Caribou Biosciences, Inc.

Caribou Biosciences, Inc. is a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company. It is engaged in developing transformative therapies for patients with devastating diseases. Its gen ...

EUTILEX.CO.,LTD 53 M $
Logo Eutilex.Co.,Ltd

Eutilex Co., Ltd. is a Korea-based company mainly engaged in the production and sale of immunotherapy products. Major products include anticancer T cell therapies and antibody therapies. ...

TELETOUCH COMMUNICATIONS, INC. 49 $
Logo Teletouch Communications, Inc.

Teletouch Communications, Inc. (Teletouch) offers a suite of telecommunications products and services, including cellular, two-way radio, global positioning system (GPS)-telemetry, wireless messaging and public safety equipment. The Company is an authoriz ...

POLTREG S.A. 56 M $
Logo Poltreg S.A.

Poltreg SA is a Poland-based company engaged primarily in biotechnology and medical research. The Company conducts research in the field of autoimmunological diseases. The Company works on a method of healing, that uses t-regulated cells (TREGs). The Firm ...

ULTIMOVACS ASA 28 M $
Logo Ultimovacs ASA

Ultimovacs ASA is a Norway-based pharmaceutical company developing immunotherapies against cancer. Ultimovacs’ technology is based on preclinical and clinical research on immunotherapies conducted at the Oslo University Hospital. Ultimovacs is advancing ...

NOILE-IMMUNE BIOTECH INC. 50 M $
Logo Noile-Immune Biotech Inc.

Noile-Immune Biotech Inc is a Japan-based company mainly engaged in the development of chimeric antigen receptor T (CAR-T) cell therapy for solid tumors using proprietary technology. The Cancer Immunotherapy Drug Discovery Business segment develops variou ...

T SCIENTIFIC CO.,LTD. 54 M $
Logo T Scientific Co.,Ltd.

T Scientific Co Ltd, formerly Omnitel Inc, is a Korea-based company mainly engaged in the provision of mobile coupons. The Company mainly sells mobile gift certificates and provides mobile commerce solution services. ...

NEOIMMUNETECH, INC. 22 M $
Logo NeoImmuneTech, Inc.

NeoImmuneTech, Inc. is a clinical-stage T cell-focused biopharmaceutical company. The Company is engaged in the discovery and development of immuno-therapeutics. Its lead asset includes NT-I7 (efineptakin alfa), which is a T Cell Amplifier. NT-I7 is a hum ...

SUPER FINE KNITTERS LIMITED 2 M $
Logo Super Fine Knitters Limited

Super Fine Knitters Limited is an India-based company, which is engaged in the business of manufacturing knitted apparels/fabrics for itself as well as for national and international brands. The Company has a laboratory which is fully equipped for tests a ...

TANA RESOURCES CORP. 667 606 $
Logo Tana Resources Corp.

Tana Resources Corp. is a Canadian mining exploration company. The Company is engaged in the acquisition, exploration and development of resource properties. The Company’s The King - Double T Property is located north of the Iskut River in northwest Bri ...


1234Next

Insiders

Picture Bernd Reh
Bernd Reh

Mr. Bernd Reh is a Head-Research & Press Contact at Commerzbank AG.


Picture Bernd Widera
Bernd Widera

Bernd Widera is a businessperson who has been at the helm of 6 different companies. Dr. Widera holds the position of Chairman-Supervisory Board of RWE Effizienz GmbH. Dr. Widera is also on the board of Lechwerke AG (former Chairman-Supervisory Board) and AVU AG für Versorgungs-Unternehmen. Dr. Widera previously occupied the position of Chairman-Supervisory Board for VSE AG, Chairman-Supervisory Board of envia Mitteldeutsche Energie AG, Chairman-Supervisory Board for RWE Vertrieb AG, Chairman-Supervisory Board for Süwag Energie AG and Chief Sales Officer at innogy Netze Deutschland GmbH. Bernd Widera received a graduate degree and a doctorate from Ruhr Universität Bochum.


Picture Bernd Brinker
Bernd Brinker

Bernd Brinker currently works at Dorma-Vertrieb-International GmbH, as Co-Managing Director, Skyfold, Inc., as Treasurer & Director from 2017, and GEA Group AG, as Chief Financial Officer from 2023.
Mr. Brinker also formerly worked at DORMA-Glas GmbH, as Co-Managing Director, Evonik Operations GmbH, as Head-Finance & Communication in 2010, SKW Trostberg AG, as Head-Finance from 1991 to 2001, Dorma Holding GmbH + Co. KGaA, as Chief Financial Officer from 2014 to 2015, Evonik Industries AG, as Head-Investor Relations from 2010 to 2011, Degussa AG, as Head-Corporate Portfolio Management, M&A from 2009 to 2014, and dormakaba Holding AG, as Chief Financial Officer & IR Contact.
Mr. Brinker received his undergraduate degree from Universität zu Köln.


Picture Bernd Maier
Bernd Maier

Bernd Maier is Head-Operations of Bâloise Holding AG.


Picture Bernd Kundrun
Bernd Kundrun

Founder of Start 2 Ventures Beteiligungsgesellschaft and Hanse Ventures BSJ GmbH, Bernd Kundrun is a German businessperson who has been at the head of 5 different companies and presently is Chairman-Supervisory Board for CTS Eventim AG & Co. KGaA. Dr. Kundrun is also Managing Partner at Start 2 Ventures GmbH and Partner at betterplace.org and on the board of 5 other companies. Dr. Kundrun previously occupied the position of Chairman-Supervisory Board at gut.org gemeinnützige AG, Member-Executive Board at Bertelsmann SE & Co. KGaA Chairman & Chief Executive Officer for Gruner + Jahr GmbH and Chairman-Management Board at Bertelsmann Club GmbH (both are subsidiaries of Bertelsmann SE & Co. KGaA) and Managing Director at Premiere Medien GmbH & Co. KG. Dr. Kundrun received an undergraduate degree from the University of Münster and an MBA from the University of Innsbruck.


Picture Bernd Hirsch
Bernd Hirsch

Presently, Bernd Hirsch occupies the position of Chief Executive Officer for IOLTECH SA. Mr. Hirsch is also on the board of 6 other companies. In the past he occupied the position of Chief Financial Officer of Bertelsmann SE & Co. KGaA, Chief Financial Officer for Carl Zeiss Meditec AG, Head-Mergers & Acquisitions at Carl Zeiss AG and Audit Manager at Arthur Andersen & Co. GmbH. He received an undergraduate degree from Julius-Maximilians-Universität Würzburg.


Picture Bernd Tönjes
Bernd Tönjes

Mr. Bernd Tönjes is a Chairman-Supervisory Board at Evonik Industries AG, a Chairman-Management Board at RAG-Stiftung, a Chairman-Supervisory Board at RAG AG, a Chairman at Deutsche Steinkohle AG and a Chairman-Management Board at Rag Anthrazit Ibbenbüren GmbH. He is on the Board of Directors at DEKRA eV. Mr. Tönjes was previously employed as a Chairman-Supervisory Board by RAG Deutsche Steinkohle AG, an Operations Director-Heinrich Robert Coal Mine by Ruhrkohle Westfalen AG, and a Manager by Bergbau AG. He received his undergraduate degree from RWTH Aachen University.


Picture Bernd Leukert
Bernd Leukert

Bernd Leukert is on the board of Bertelsmann SE & Co. KGaA, TomTom International BV, TomTom Germany GmbH & Co. KG and Bertelsmann Management SE and Chief Technology, Data & Innovation Officer at Deutsche Bank AG and Member-Market Strategy Board at International Electrotechnical Commission. Mr. Leukert previously occupied the position of Head-Products & Innovation at SAP SE. He received an MBA from the University of Karlsruhe.


Bernd Osterloh
Bernd Osterloh

Bernd Osterloh is Chairman of Forderverein Ready4work E.V. Mr. Osterloh is also on the board of 14 other companies. In his past career he was Member-Supervisory Board at Porsche Automobil Holding SE.


Picture Bernd Böddeling
Bernd Böddeling

Bernd Böddeling is a businessperson who has been the head of 6 different companies and currently holds the position of Chairman-Supervisory Board at Lechwerke AG, Chairman-Supervisory Board at Rheinisch-Westfälische Wasserwerksgesellschaft mbH, Chairman-Supervisory Board at VSE AG, Chairman-Supervisory Board of envia Mitteldeutsche Energie AG, Chairman-Supervisory Board at Emscher Lippe Energie GmbH and Chairman for Süwag Energie AG. Bernd Böddeling is also on the board of RheinEnergie AG and medl GmbH. In his past career he was Chief Financial Officer, Director & EVP at innogy Netze Deutschland GmbH, Head-Controlling at RWE Energy AG, Head-Controlling at RWE Plus AG and Member-Executive Board at RWE Rhein Ruhr AG. He received an undergraduate degree from Universität Paderborn.


Picture Bernd Greifeneder
Bernd Greifeneder

Bernd Greifeneder is an entrepreneur who founded Dynatrace, Inc., ARC, Inc. and Dynatrace LLC. Currently, Mr. Greifeneder occupies the position of Chief Technology Officer & Senior Vice President for Dynatrace, Inc. In his past career Bernd Greifeneder was Chief Technology Officer for Dynatrace LLC and Chief Technology Officer for Segue Software, Inc. He received a graduate degree and an undergraduate degree from Johannes Kepler Universität Linz.


Bernd Pischetsrieder
Bernd Pischetsrieder

Dr. Bernd Pischetsrieder is a Chairman-Supervisory Board at Daimler AG and a Vice President at Deutsche Akademie der Technikwissenschaften eV. He is on the Board of Directors at Tetra Laval International SA, Mercedes-Benz AG (Germany) and Wittelsbacher Ausgleichsfonds. Dr. Pischetsrieder was previously employed as a Chairman-Supervisory Board by Münchener Rückversicherungs-Gesellschaft AG, a Chairman-Supervisory Board by Volkswagen AG, a Member-Supervisory Board by METRO AG /Old/, a Director-Production, Development & Purchasing by BMW South Africa Pty Ltd., a Chairman-Management Board by Bayerische Motoren Werke AG, and a Member-Supervisory Board by ERGO Group AG. He also served on the board at Dresdner Bank AG and SCANIA AB. He received his undergraduate degree from Technische Universität München.


Picture Bernd Sauter
Bernd Sauter

Bernd Sauter is a businessperson who has been the head of 7 different companies and presently is Managing Director at Landwirtschaftsgesellschaft mbH Neukammer, Chief Executive Officer of Alois Sauter Landesprodukten-Großhandlung GmbH & Co.KG, Co-Managing Director at LANDGUT Coschen GmbH and Co-Chief Operating Officer-Procurement & Logistics at VERBIO Vereinigte BioEnergie AG. He is also on the board of Verbio North America Corp. and Co-Managing Director at Sauter Verpachtungsgesellschaft mbH. He previously held the position of Chief Executive Officer at Autokontor Bayern GmbH, Chief Executive Officer & Managing Director at Landwirtschaftsgesellschaft mbH Neukammer, Chief Executive Officer & Managing Director at LANDGUT Coschen GmbH and Managing Partner at AllEn GmbH.


Picture Bernd Hugo Eulitz
Bernd Hugo Eulitz

Bernd Hugo Eulitz is currently the Chief Executive Officer at Messer SE & Co. KGaA (Germany).
He is also a Director at Linde Gas Singapore Pte Ltd., Linde Gas Asia Pte Ltd., Linde (Thailand) Plc, Linde Malaysia Holdings Sdn.
Bhd., Linde Philippines, Inc., and Linde Gas Vietnam Ltd.
Previously, he was the Chief Executive Officer at PanGas AG and Chairman at African Oxygen (Pty) Ltd.
He also served as Chairman-Management Board at Knorr-Bremse AG and Executive Vice President-Americas at Linde plc.
He has held various directorial positions at Pakistan Oxygen Ltd., Linde Bangladesh Ltd., Ceylon Oxygen Ltd., and Linde GmbH.
Mr. Eulitz started his career as Head-Logistics at Air Liquide Deutschland GmbH and later worked as a Project Manager at A.T.
Kearney GmbH.
He holds a graduate degree from the University of Karlsruhe.


Picture Bernd Michael Gschaider
Bernd Michael Gschaider

Bernd Michael Gschaider is a businessperson who has been the head of 6 different companies and currently occupies the position of Chief Operating Officer for Zur Rose Group AG, Managing Director at Amazon Deutschland Transport GmbH, Co-Managing Director at Amazon Deutschland W1 Transport GmbH and Co-Managing Director at Amazon Deutschland E1 Transport GmbH. He is also on the board of Amazon Logistik GmbH. In the past Mr. Gschaider was Co-Managing Director at Amazon Koblenz GmbH, Co-Managing Director at Amazon Fulfillment Germany GmbH and Co-Managing Director at Amazon FC Graben GmbH.



Picture Bernd Kortüm
Bernd Kortüm

Bernd Kortüm founded Norddeutsche Vermögensanlage GmbH & Co. KG in 1975, where he is working as Co-Managing Director from 1975 and Norddeutsche Vermögen Holding GmbH & Co. KG in 1945, where he worked as Chairman-Management Board from 1975 to 2021.
Dr. Kortüm also currently works at Norddeutsche Reederei H.
Schuldt GmbH & Co. KG, as Co-Managing Director and INTEGRA Holding GmbH & Co. KG, as Co-Managing Director.



Picture Bernd H. Schmidt
Bernd H. Schmidt

Bernd H.
Schmidt
is the founder of DIaLOGIKa — Gesellschaft für angewandte Informatik mbH, which was founded in 1982.
He is currently a Director at Dokumenta AG since 1986 and a Member-Supervisory Board at Drillisch Telecom GmbH.
He previously served as a Member-Supervisory Board at Drillisch AG.
Dr. Schmidt received his undergraduate degree from Universität des Saarlandes in 1976.





Picture Bernd Munding
Bernd Munding

Bernd Munding is currently a Member-Supervisory Board at EnBW Operations GmbH.
Previously, he worked as a Member-Supervisory Board at EnBW Energie Baden Württemberg AG from 2011 to 2013.


Picture Bernd Dautel
Bernd Dautel

Bernd Dautel is currently a Non-Executive Director at De.Mem Pte Ltd., De.mem Ltd., and De.
Mem-Akwa Pty Ltd.
He is also a Director & Partner at New Asia Investments Pte Ltd.
Previously, he served as the Managing Director-Asia Pacific at Wieland Metals Singapore Pte Ltd.
from 1994 to 2012.
He also held positions as a Director at NA Singapore Management Pte Ltd., Stella Specialty Chemicals (S) Pte Ltd., and President & Director at International Copper Association Southeast Asia Ltd.
Mr. Dautel graduated from Karlsruher Institut für Technologie.









Picture Bernd Rothenberger
Bernd Rothenberger

Bernd Rothenberger is currently the Co-Managing Director at Werkzeugmaschinenbau Sinsheim GmbH and the Managing Partner at ROVEST Beratung & Beteiligung GmbH.
He previously worked as the Director at Rothenberger Werkzeuge AG from 1988 to 2002, Managing Director at Debag GmbH from 2004 to 2006, Head-Procurement & Logistic at Rothenberger Werkzeuge GmbH from 1982 to 1986, and Member at Industrie- und Handelskammer Frankfurt am Main from 1995 to 2004.
He also served as the Chief Sales Officer at DVS Technology AG from 2010 to 2021.
Mr. Rothenberger received his undergraduate degree from the University of Mannheim in 1981.




Picture Bernd Geißendörfer
Bernd Geißendörfer

Bernd Geißendörfer is currently working as the Group Head-Finance at HPI AG.
He completed his undergraduate degree at Fachhochschule Worms.



Picture Bernd Kottmann
Bernd Kottmann

Bernd Kottmann served as the Chief Operating Officer-Real Estate Business at IVG Immobilien GmbH and as the Vice Chairman-Supervisory Board at Hamborner REIT AG.
He also briefly served as the Chairman-Management Board & CEO at GSW Immobilien AG.
Kottmann received his undergraduate degree from the University of Münster in 1981 and his doctorate from Universitaet der Bundeswehr Muenchen in 1986.




















Picture Bernd Meyer
Bernd Meyer

Dr. Bernd Meyer is a Chief Strategist at Joh.
Berenberg, Gossler & Co. KG.
Dr. Meyer started his career in 1998 at Deutsche Bank, where he was Head of the European Equity Strategy.
In early 2010, he moved from Deutsche Bank in London to Commerzbank, where he established the Global Cross Asset Strategy Research as head of the division.
At Commerzbank, Dr. Meyer also contributed to designing and developing multi-asset funds and strategy ETFs.







Picture Bernd Eikens
Bernd Eikens

Bernd Eikens is currently the Chief Executive Officer at MEYER WERFT GmbH & Co. KG.
He is also the Vice Chairman-Supervisory Board at Rudolf Bunte Beteiligungs GmbH, Director at German Pulp & Paper Association, Director at Euro-Graph Asbl, and Member-Supervisory Board at JOHANN BUNTE Bauunternehmung GmbH & Co. KG.
Previously, Dr. Eikens worked as the Managing Director at NordlandsBanken ASA, Director at Paprican, Inc., Senior Process Engineer at International Paper Co., Executive Vice President-UPM Biorefining at UPM-Kymmene Oyj, President at UPM-Kymmene, Inc., and Executive Vice President at UPM Communication Papers Oy.
Dr. Eikens holds a doctorate degree from Colorado State University.




Picture Bernd Kappesser
Bernd Kappesser

Bernd Kappesser has worked as a Director of Marketing at Danet GmbH since 1997 and as a Chief Operating Officer at REALTECH AG since 2018.


Picture Bernd O. Wetzel
Bernd O. Wetzel

Bernd O.
Wetzel
currently works at Atugen AG, as Member.
Dr. Wetzel also formerly worked at DeveloGen AG, as Deputy Chairman-Supervisory Board from 2009 to 2012, Silence Therapeutics Plc, as Non-Executive Director, Biovertis AG, as Director-Supervisory Board from 2009 to 2012, Biofrontera AG, as Member-Supervisory Board from 2011 to 2012, DIREVO Biotech AG, as Member-Supervisory Board, Ludwig-Maximilians-Universität München, as Professor, and Gruner Böhringer AG, as Chief Scientific Officer.




Picture Bernd Steffen Quade
Bernd Steffen Quade

Bernd Steffen Quade is currently the Managing Director and Co-Managing Director at SAHLBERG GmbH & Co. KG and SAHLBERG GmbH respectively.
Previously, he served as a Member-Supervisory Board at Curanum AG from 2009 to 2011 and as the Chief Financial Officer at SimonsVoss Technologies GmbH.


Picture Bernd Girod
Bernd Girod

Dr. Bernd Girod is a Principal at Stanford University.
He is on the Board of Directors at TokBox, Inc. and Droplet Technology, Inc. Dr. Girod was previously employed as a Principal by The Institute of Electrical & Electronics Engineers, Inc. He also served on the board at 8x8, Inc., Dyyno, Inc., Polycom, Inc., RealNetworks, Inc., and Vivo Software, Inc. He received his graduate degree from the Georgia Institute of Technology and a doctorate degree from the University of Hannover.





Picture Bernd Lieding
Bernd Lieding

Bernd Lieding is currently a Co-Managing Director at Mauer Thüringen GmbH and dormakaba EAD GmbH.







Picture Bernd Thielk
Bernd Thielk

Bernd Thielk currently works at ANGA Association of German Cable Operators, as Vice President.


Picture Bernd Jonas
Bernd Jonas

Bernd Jonas is currently a Trustee at Institut Finanzen und Steuern eV.
He previously served as Chairman-Supervisory Board at Hoesch AG, Director at TK Elevator (Canada) Ltd., and Executive Vice President at thyssenkrupp AG.
He also served as a Member-Supervisory Board at Siltronic AG, TK Elevator GmbH, and thyssenkrupp Industrial Solutions AG.
Additionally, he was a Member of the Auditor Oversight Commission and the Tax Code Commission at Stiftung Marktwirtschaft.
Mr. Jonas received a graduate degree from the University of Bonn in 1974.


Picture Bernd Schiphorst
Bernd Schiphorst

Bernd Schiphorst is the Chairman-Supervisory Board of media.net berlinbrandenburg e.V.
since founding the company in 2000.
He was the President & Chief Executive Officer of AOL Europe SARL (France) and Bertelsmann New Media.
He also served as the Managing Director & Member-Executive Board of Markte & Medien GmbH and Head-Executive Affairs of Gruner + Jahr Deutschland GmbH.
Mr. Schiphorst was a Member-Supervisory Board of ZEAL Network SE from 2013 to 2019 and a Member-Executive Board of WMP EuroCom AG.


Picture Bernd Scholz-Reiter
Bernd Scholz-Reiter

Bernd Scholz-Reiter is currently a member of the supervisory board at Deutsches Forschungszentrum für Künstliche Intelligenz GmbH.





Picture Bernd Groß
Bernd Groß

Bernd Groß is the founder of Cumulocity GmbH, which he co-managed starting in 2010.
He is currently the Chief Technology Officer at Software AG since 2019.
Mr. Groß has a graduate degree and an MBA from London Business School.







Picture Bernd Haus
Bernd Haus

Bernd Haus is currently the Managing Director at EHG Elektroholding GmbH since 2000.
He was previously a Member-Supervisory Board at PSI Software SE from 2008 to 2017.


Picture Bernd Rothe
Bernd Rothe

Bernd Rothe is the founder of cosiq GmbH, a company founded in 2016, where he holds the title of Co-Managing Director.
He is currently working as Co-Managing Director at Wohn- und Pflegezentrum Lindenhof GmbH.
In the past, he worked as Chairman-Management Board & CEO at Curanum AG from 2009 to 2010.


Picture Bernd Metzner
Bernd Metzner

Bernd Metzner is currently the Deputy Chairman-Supervisory Board at UniCredit Bank GmbH and Gerresheimer Tettau GmbH.
He is also the Co-Managing Director at Gerresheimer Group GmbH, Gerresheimer Holdings GmbH, and Gerresheimer Glas GmbH.
Additionally, he holds the position of Director at Sensile Medical AG, Ströer Kentvizyon Reklam Pazarlama AS, Centor, Inc., Centor Pharma, Inc., Corning Pharmaceutical Packaging LLC, and Gerresheimer Glass, Inc. Furthermore, he is the Chief Financial Officer at Gerresheimer AG and a Member-Supervisory Board at Gerresheimer Regensburg GmbH.
Previously, Dr. Metzner served as the Co-Managing Director at Ströer DERG Media GmbH and Ströer SSP GmbH.
He was also an Independent Director at Anavex Life Sciences Corp.
Additionally, he held the position of Director at Centor US Holding, Inc. and was the Chief Financial Officer at Bayer AG, Ströer SE & Co. KGaA, Bayer SpA, Döhler GmbH, and Bayer Pharma AG.
He also worked as the Head-Finance & Administration at Bayer SpA and as the Head-Central Administration & Organization at Bayer Pharma AG.
Moreover, he was a Principal at Flick Glocke Schaumburg.
He served as a Member-Supervisory Board at Allane SE and tricontes360 Verwaltung Hamburg GmbH.
He was also the Chief Financial Officer at Ströer Management SE and a Member-Supervisory Board at Döhler Group SE.
Dr. Metzner holds a doctorate degree from the University of Siegen.



Picture Bernd Jacke
Bernd Jacke

Bernd Jacke is currently a Member-Supervisory Board at AVECO Holding AG.
Previously, he worked as the Chairman at WISAG Service Holding Europa GmbH from 1994 to 2008.



Picture Bernd Volk
Bernd Volk

Mr. Bernd Volk, CFA, is a Strategist at Deutsche Bank.
He has more than 14 years of investment analysis experience.
Since January 2007, he is responsible for covered bond, sub-sovereign, and agency research at Deutsche Bank.
In 1998, Mr. Volk started as Research Analyst for Pfandbriefe at DZ Bank.
From 2000 to 2004, he worked at Deka Investment, the second-largest fund manager in Germany, as a Credit Analyst for banks and covered bonds.
From 2005 to 2006, Mr. Volk worked at HVB as a Credit Analyst for covered bonds.
Mr. Volk graduated from the University of Freiburg with a degree in law and one in economics.
He served as an assistant professor for two and a half years at the University of Freiburg and holds the Chartered Financial Analyst (CFA) designation.


Picture Bernd Wagner
Bernd Wagner

Bernd Wagner is a professional with a background in business.
He is currently a Director at E.ON UK Infrastructure Services Ltd.
He previously held positions as Chairman at Slovensky plynarensky Priemysel AS, and as Director at E.ON UK CHP Ltd.
and Citigen (London) Ltd.
Mr. Wagner received his undergraduate degree from Ruhr-Universität Bochum in 1992.

No results for this search